359
Participants
Start Date
October 25, 2016
Primary Completion Date
June 30, 2025
Study Completion Date
June 30, 2025
Carfilzomib
In accordance with SmPC.
Centrum für Hämatologie und Onkologie Bethanien, Frankfurt
Collaborators (1)
Amgen
INDUSTRY
iOMEDICO AG
INDUSTRY